Immunocore Holdings (IMCR) Tax Provisions (2021 - 2026)
Immunocore Holdings (IMCR) posted Tax Provisions of $301000.0 for Q1 2026, down 97.89% sequentially from $14.3 million in Q4 2025, and down 72.64% YoY from $1.1 million in Q1 2025.
Immunocore Holdings (IMCR) Tax Provisions (2021 - 2026) Analysis & Trends
Immunocore Holdings has reported Tax Provisions for 6 years, with the latest figure at $301000.0 in Q1 2026.
- Quarterly Tax Provisions fell 72.64% year-over-year to $301000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (up 1533.94% YoY) and the FY2025 annual result came in at $16.4 million, up 987.24% from the prior year.
- Tax Provisions slipped to $301000.0 in Q1 2026 per IMCR's latest filing, from $14.3 million in the prior quarter.
- Over five years, Tax Provisions peaked at $14.3 million in Q4 2025 and troughed at -$5.9 million in Q4 2023.
- A 5-year average of $481704.1 and a median of $300500.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions plunged 1410.29% in 2024, then surged 1458.67% in 2025.
- Over 5 years, Tax Provisions stood at $2.5 million in 2022, then sank by 336.71% to -$5.9 million in 2023, then surged by 82.24% to -$1.0 million in 2024, then soared by 1458.67% to $14.3 million in 2025, then sank by 97.89% to $301000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $301000.0, $14.3 million, and $500000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Immunocore Holdings | 1.76 Bn | 880.92 Mn | 114.84 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 301,000.00 |
| Dec 31, 2025 | 14.27 Mn |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 606,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | -1.05 Mn |
| Sep 30, 2024 | -2.64 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | -5.91 Mn |
| Sep 30, 2023 | -175,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 2.50 Mn |
| Sep 30, 2022 | -1.47 Mn |
| Jun 30, 2022 | -2.71 Mn |
| Dec 31, 2021 | 288,474.27 |
| Sep 30, 2021 | -2.93 Mn |